Top Markets
#1 ADO Protocol ADO Protocol +329.47%
#2 GoPlus Security GoPlus Security +54.27%
#3 Nockchain Nockchain +46.24%
#4 Tutorial Tutorial +35.05%
#5 Starpower Starpower +34.11%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.96%
#7 The Black Bull The Black Bull +31.29%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +21.33%
#10 Verus Coin Verus Coin +20.40%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
China Regenerative Medicine International Limited China Regenerative Medicine International Limited

China Regenerative Medicine International Limited

8158
Rank in Stocks #32811
China Regenerative Medicine International Limited operates as an investment... China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
Share Price
$0.02967889
Last synced: 2026-08-12
Market Cap
$9.03M
Change (1 day)
0.00%
Change (1 year)
-72.68%
Country
HK
Trade China Regenerative Medicine International Limited (8158)

Category

Healthcare
Earnings for China Regenerative Medicine International Limited (8158)
Earnings in 2026 TTM: 0
According to China Regenerative Medicine International Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for China Regenerative Medicine International Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE